Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 2, Issue 11
1 November 2003
Issue Cover
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion
Xueyan Wang; Phuong Le; Congxin Liang; Julie Chan; David Kiewlich; Todd Miller; Dave Harris; Li Sun; Audie Rice; Stefan Vasile; Robert A. Blake; Anthony R. Howlett; Neela Patel; Gerald McMahon; Kenneth E. Lipson
View articletitled, Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion
Open the PDF for in another window
Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation
Sudhir B. Kondapaka; Sheo S. Singh; Girija P. Dasmahapatra; Edward A. Sausville; Krishnendu K. Roy
View articletitled, Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation
Open the PDF for in another window
A novel low molecular weight antagonist of vascular endothelial growth factor receptor binding: VGA1155
Yasuji Ueda; Takehiro Yamagishi; Kazunori Samata; Hisao Ikeya; Noriko Hirayama; Hajime Takashima; Shiro Nakaike; Makoto Tanaka; Ikuo Saiki
View articletitled, A novel low molecular weight antagonist of vascular endothelial growth factor receptor binding: VGA1155
Open the PDF for in another window
Sensitization of breast cancer cells to radiation by trastuzumab
Ke Liang; Yang Lu; Weidong Jin; K. Kian Ang; Luka Milas; Zhen Fan
View articletitled, Sensitization of breast cancer cells to radiation by trastuzumab
Open the PDF for in another window
Replication and episomal maintenance of Epstein-Barr virus-based vectors in mouse embryonal fibroblasts enable synthetic lethality screens
Yulia Einav; Elena Shistik; Michal Shenfeld; Arnold H. Simons; David W. Melton; Dan Canaani
View articletitled, Replication and episomal maintenance of Epstein-Barr virus-based vectors in mouse embryonal fibroblasts enable synthetic lethality screens
Open the PDF for in another window
Phage probes for malignant glial cells
Tatiana I. Samoylova; Valery A. Petrenko; Nancy E. Morrison; Ludmila P. Globa; Henry J. Baker; Nancy R. Cox
View articletitled, Phage probes for malignant glial cells
Open the PDF for in another window
Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: A possibility of tyrosine kinase inhibitor of growth factor
Hiroji Uemura; Hitoshi Ishiguro; Noboru Nakaigawa; Yoji Nagashima; Yasuhide Miyoshi; Kiyoshi Fujinami; Akihiro Sakaguchi; Yoshinobu Kubota
View articletitled, Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: A possibility of tyrosine kinase inhibitor of growth factor
Open the PDF for in another window
Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3
James D. Anderson; Todd P. Hansen; Paul W. Lenkowski; Alison M. Walls; Indrani M. Choudhury; Hilary A. Schenck; Mati Friehling; Genevieve M. Höll; Manoj K. Patel; Robert A. Sikes; Milton L. Brown
View articletitled, Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3
Open the PDF for in another window
Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells
Jennifer McCafferty-Grad; Nizar J. Bahlis; Nancy Krett; Tatiana M. Aguilar; Isildinha Reis; Kelvin P. Lee; Lawrence H. Boise
View articletitled, Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells
Open the PDF for in another window
Phycocyanin-mediated apoptosis in AK-5 tumor cells involves down-regulation of Bcl-2 and generation of ROS
Bobbili V.V. Pardhasaradhi; A. Mubarak Ali; A. Leela Kumari; Pallu Reddanna; Ashok Khar
View articletitled, Phycocyanin-mediated apoptosis in AK-5 tumor cells involves down-regulation of Bcl-2 and generation of ROS
Open the PDF for in another window
Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies
Kyoung Jin P. Yoon; Erik J. Krull; Christopher L. Morton; William G. Bornmann; Richard E. Lee; Philip M. Potter; Mary K. Danks
View articletitled, Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies
Open the PDF for in another window
Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis
Ali R. Jazirehi; Xiao-Hu Gan; Sven De Vos; Christos Emmanouilides; Benjamin Bonavida
View articletitled, Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis
Open the PDF for in another window
Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein
Tracy Brooks; Hans Minderman; Kieran L. O'Loughlin; Paula Pera; Iwao Ojima; Maria R. Baer; Ralph J. Bernacki
View articletitled, Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein
Open the PDF for in another window
Involvement of oligosaccharide changes in α5β1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line
Susumu Nakahara; Eiji Miyoshi; Katsuhisa Noda; Shinji Ihara; Jianguo Gu; Koichi Honke; Hidenori Inohara; Takeshi Kubo; Naoyuki Taniguchi
View articletitled, Involvement of oligosaccharide changes in α5β1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line
Open the PDF for in another window
Glycogen synthase kinase-3β suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer
Xinbo Liao; Liping Zhang; J. Brantley Thrasher; Jie Du; Benyi Li
View articletitled, Glycogen synthase kinase-3β suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer
Open the PDF for in another window
Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity
Nand K. Sah; Anupama Munshi; Takashi Nishikawa; Tapas Mukhopadhyay; Jack A. Roth; Raymond E. Meyn
View articletitled, Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity
Open the PDF for in another window
Systemic dissemination of viral vectors during intratumoral injection
Yong Wang; Jim Kang Hu; Ava Krol; Yong-Ping Li; Chuan-Yuan Li; Fan Yuan
View articletitled, Systemic dissemination of viral vectors during intratumoral injection
Open the PDF for in another window

Review

α-Fetoprotein growth inhibitory peptides: Potential leads for cancer therapeutics
Gerald J. Mizejewski; Robert MacColl
View articletitled, α-Fetoprotein growth inhibitory peptides: Potential leads for cancer therapeutics
Open the PDF for in another window

Advertisement

Breaking
UK-wide Immunotherapy Collaboration Launches
Some Acne Creams Found to Contain Known Carcinogen
Breast Cancer Incidence Up by Half in AAPI Women
View more recent articles
Latest News
Nobel-Winning AI Advances Are Transforming Cancer Research
MicroRNAs, Focus of Nobel Prize, Highlight Untapped Potential
COVID-19 Vaccines Linked to Improved Survival in ICI-Treated Cancers
View more recent articles
Research Watch
Epigenetic Modification of Centromeric RNA Supports Genomic Stability
Patient Response to Immunotherapy Is Dictated by Five Latent Factors
Type 2 Immune Factors Enhance T Cell–Driven Antitumor Immune Responses
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept